Michael L. Krall

Michael L. Krall

Michael L. Krall is the President, CEO and Chairman of PURE Bioscience, a position he has held since 1993. Originally founded as a pharmaceutical device company, PURE has a long history of operating in the highly regulated pharmaceutical industry. The original device division was sold in 2005 after which PURE turned its complete attention and resources to developing and commercializing its new molecular entity, silver dihydrogen citrate, as a broad spectrum antimicrobial platform. With more than 30 years experience as an entrepreneur and businessman, Mr. Krall’s prior leadership roles also include ownership and executive management of a successful residential and commercial building and development company.